ArticleRSC medicinal chemistry2022

Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model.

Philipp Spatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.